Abgenix Inc (1052837) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, December 31, 2003

1052837 Annual Reports

10-K Annual Report March 2006

10-K Annual Report March 2005

10-K Annual Report March 2004
Select PDF Feature:

Include Exhibits

Highlight YoY Changes

10-K Only

1052837 Quarterly Reports

10-Q Quarterly Report November 2005

10-Q Quarterly Report August 2005

10-Q Quarterly Report May 2005

10-Q Quarterly Report November 2004

10-Q Quarterly Report August 2004

1052837 Corporate News

Financial Exhibit
Other Events

March 2006

Earnings Release
Financial Exhibit

February 2006

December 2005

December 2005

Financial Exhibit
New Agreement
Regulated Disclosure

December 2005

Financial Exhibit
Other Events

November 2005

Earnings Release
Financial Exhibit

October 2005

Bylaw Change
Financial Exhibit

September 2005

Financial Exhibit
Other Events

August 2005

Earnings Release
Financial Exhibit

July 2005

Abgenix Inc

HISTORY TOOLS

CIK: 1052837

Please wait while we load the requested 10-K report or click the link below:

https://last10k.com/sec-filings/report/1052837/000104746904007485/a2130226z10-k.htm

View differences made from one year to another to evaluate Abgenix Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Abgenix Inc.

Continue

Assess how Abgenix Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A) — Screenshot example of actual Proxy Statement

Abgenix Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2004 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Material Contracts, Statements, Certifications & more

Abgenix Inc provided additional information to their SEC Filing as exhibits

Exhibit 4.11: Instruments Defining The Rights Of Security Holders, Including Indentures

Exhibit 23.1: Consents Of Experts And Counsel

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification

Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification

Exhibit 32.1: Section 1350 Certification

Exhibit 32.2: Section 1350 Certification

CIK: 1052837
Form Type: 10-K Annual Report
Accession Number: 0001047469-04-007485
Submitted to the SEC: Thu Mar 11 2004 2:54:29 PM EST
Accepted by the SEC: Thu Mar 11 2004
Period: Wednesday, December 31, 2003
Industry: Biological Products No Disgnostic Substances

External Resources:

Bookmark the Permalink:
https://last10k.com/sec-filings/1052837/0001047469-04-007485.htm